Dr Pia Garguilo and Richard Watts join Qiagen
pharmafile | April 27, 2010 | Appointment | Sales and Marketing | Qiagen, appointment, sales and marketing
Netherlands-based diagnostics company Qiagen has made two appointments to its new pharma business development team.
Dr Pia Gargiulo joins as senior director of pharma business development, and Richard Watts will assume a new role as director of pharma business development.
The pharma business development team, established to oversee all new drug-diagnostic co-development programmes with pharma companies, has a global reach with members based in Manchester and Crawley in the UK, and in Dallas and Chicago in the US.
Dr Pia Gargiulo, who will be based in Chicago, joins Qiagen from the medical affairs/oncology department of AstraZeneca in the US, where she was a senior regional scientific manager working with breast, lung, colorectal and prostate cancer pipelines.
She has over 15 years experience in industry and academia with a strong focus in oncology.
Prior to her time at AstraZeneca Pia worked with Oncor, and later Vysis, to support development of their respective Her2 diagnostics, and specialised in Leukemia research at the Northwestern Medical School and University of Chicago.
Richard Watts is the former pharma regional marketing manager at Qiagen, a position he has held since 2006.
He has over 12 years commercial experience in next generation technologies for genetic analysis. Previously Richard worked at Invitrogen following the acquisition of DNA Research Innovations where he successfully aided in the company’s sale in 2004.
He has also held positions at Nanogen, Packard Bioscience and Bio-Rad. Richard has a BSc in Molecular Biology from Bath University, he is an associate fellow of the Royal Society of Medicine in the UK.
Related Content
QIAGEN and INOVIO to develop diagnostic tests for cervical dysplasia treatment
QIAGEN and INOVIO Pharmaceuticals have extended their collaboration to develop a new diagnostic test which …
Myeloma UK reveals new Director of Research appointment
UK non-profit organisation Myeloma UK has selected Sarah McDonald as its new Director of Research, …
Abbott CEO to step down after 21 years
After more than two decades at the head of the company, it has emerged that …
